Cargando…
Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance eva...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939119/ https://www.ncbi.nlm.nih.gov/pubmed/35313809 http://dx.doi.org/10.1186/s12872-021-02421-8 |
_version_ | 1784672678765920256 |
---|---|
author | Rodríguez-Esparragón, Francisco Torres-Mata, Laura B. López-Fernández, Juan Carlos Cappiello, Laura González-Martín, Jesús M. Clavo, Bernardino Serna-Gómez, Jaime A. Estupiñán-Quintana, Lidia Torres-Ascensión, Cristina Villar, Jesús |
author_facet | Rodríguez-Esparragón, Francisco Torres-Mata, Laura B. López-Fernández, Juan Carlos Cappiello, Laura González-Martín, Jesús M. Clavo, Bernardino Serna-Gómez, Jaime A. Estupiñán-Quintana, Lidia Torres-Ascensión, Cristina Villar, Jesús |
author_sort | Rodríguez-Esparragón, Francisco |
collection | PubMed |
description | BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated. METHODS: This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs. RESULTS: CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01–6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2–15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay. CONCLUSIONS: Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs. |
format | Online Article Text |
id | pubmed-8939119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89391192022-03-23 Clinical relevance of circulating angiogenic cells in patients with ischemic stroke Rodríguez-Esparragón, Francisco Torres-Mata, Laura B. López-Fernández, Juan Carlos Cappiello, Laura González-Martín, Jesús M. Clavo, Bernardino Serna-Gómez, Jaime A. Estupiñán-Quintana, Lidia Torres-Ascensión, Cristina Villar, Jesús BMC Cardiovasc Disord Research Article BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated. METHODS: This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs. RESULTS: CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01–6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2–15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay. CONCLUSIONS: Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs. BioMed Central 2022-03-21 /pmc/articles/PMC8939119/ /pubmed/35313809 http://dx.doi.org/10.1186/s12872-021-02421-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Rodríguez-Esparragón, Francisco Torres-Mata, Laura B. López-Fernández, Juan Carlos Cappiello, Laura González-Martín, Jesús M. Clavo, Bernardino Serna-Gómez, Jaime A. Estupiñán-Quintana, Lidia Torres-Ascensión, Cristina Villar, Jesús Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title | Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title_full | Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title_fullStr | Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title_full_unstemmed | Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title_short | Clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
title_sort | clinical relevance of circulating angiogenic cells in patients with ischemic stroke |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939119/ https://www.ncbi.nlm.nih.gov/pubmed/35313809 http://dx.doi.org/10.1186/s12872-021-02421-8 |
work_keys_str_mv | AT rodriguezesparragonfrancisco clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT torresmatalaurab clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT lopezfernandezjuancarlos clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT cappiellolaura clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT gonzalezmartinjesusm clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT clavobernardino clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT sernagomezjaimea clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT estupinanquintanalidia clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT torresascensioncristina clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke AT villarjesus clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke |